title: First results of an open phase II study with the antidepressant paroxetine.
authors.affiliation: Innsbruck University Clinics, Department of Psychiatry, Austria.
authors.forename: C
authors.initials: C
authors.lastname: Stuppäck
authors.forename: H
authors.initials: H
authors.lastname: Schubert
authors.forename: C
authors.initials: C
authors.lastname: Barnas
authors.forename: M
authors.initials: M
authors.lastname: Mair
authors.forename: I
authors.initials: I
authors.lastname: Schifferle
authors.forename: B
authors.initials: B
authors.lastname: Unterweger
authors.forename: L
authors.initials: L
authors.lastname: Wömhart
authors.forename: W W
authors.initials: WW
authors.lastname: Fleischhacker
authors.forename: H
authors.initials: H
authors.lastname: Hinterhuber
mesh_terms: D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine; D010880:Piperidines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales
chemical_list: D000928:Antidepressive Agents; D010880:Piperidines; D017374:Paroxetine